Excimer Laser for Corneal Refractive Surgery

Excimer lasers are used in procedures such as photorefractive keratectomy, laser-assisted in situ keratomileusis, and laser-assisted subepithelial keratomileusis to reshape the cornea and correct refractive errors. Clinical practice emphasizes patient selection, corneal diagnostics, treatment planning, laser calibration, and postoperative monitoring. Outcomes depend on factors including baseline prescription, corneal thickness and shape, ocular-surface health, surgical technique, and adherence to follow-up care.

The field is shifting toward more individualized treatment through wavefront-guided and topography-guided planning, epithelial mapping, and more detailed screening for irregular corneal conditions. Improved eye tracking, treatment centration, and integration of diagnostic data support procedural precision. At the same time, providers are placing greater emphasis on dry-eye prevention, infection control, informed consent, enhancement policies, and long-term surveillance for ectasia and other complications.

Artificial intelligence can support corneal-image interpretation, risk stratification, surgical planning, and postoperative monitoring when trained on representative, clinically validated datasets. Pattern-recognition tools may help identify subtle abnormalities associated with keratoconus or ectasia risk, while analytics can assist in comparing preoperative and follow-up measurements. Human oversight remains essential because algorithmic outputs can be affected by image quality, population bias, incomplete records, and clinically atypical presentations.

North America has advanced refractive-surgery infrastructure, established specialist networks, and strong attention to safety documentation and patient-reported outcomes. Europe combines mature clinical practice with regulatory and data-governance requirements that encourage standardized evaluation. Asia-Pacific includes sophisticated urban centers alongside substantial access gaps, with demand shaped by large patient populations, surgeon training, and private-care capacity. Latin America is influenced by medical-tourism activity, uneven purchasing power, and concentration of advanced equipment in major cities. The Middle East shows expanding private ophthalmology services, while Africa remains highly heterogeneous, with access constrained by equipment costs, specialist availability, maintenance, and referral pathways.

ASEAN markets differ widely in healthcare financing, urban concentration, and specialist capacity, making training and service support important adoption factors. BRICS members span established refractive centers and settings where affordability, import procedures, and infrastructure remain decisive. European Union practice is shaped by shared regulatory principles alongside national reimbursement and clinical pathways. G7 countries generally have strong diagnostic and surgical capabilities but face heightened expectations for evidence, cybersecurity, and patient safety. GCC states often benefit from concentrated investment in private healthcare and advanced facilities, whereas NATO members vary considerably in public-sector access, procurement, and clinical workforce capacity.

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally operate within mature ophthalmic ecosystems, with adoption influenced by clinical evidence, regulation, surgeon expertise, and private-pay models. China and India combine substantial unmet need with rapidly developing specialist capacity, but access differs sharply by city, institution, and income. Brazil and Mexico have established refractive-surgery activity alongside regional affordability and infrastructure disparities. Russia’s deployment is affected by economic conditions, equipment access, and healthcare-system constraints. Across all countries, screening quality, postoperative care, and transparent communication about benefits and limitations remain central to safe expansion.

Providers should establish consistent eligibility protocols using tomography, pachymetry, refraction, ocular-surface assessment, and documented contraindication checks. They should invest in surgeon and technician training, preventive maintenance, laser-quality controls, infection prevention, and structured follow-up that captures visual outcomes and adverse events. Decision-makers should evaluate systems on clinical utility, interoperability, service support, total ownership requirements, and data protection rather than procedural throughput alone. Partnerships with referral networks can improve screening and complication management, while patient education should clearly address alternatives, recovery, enhancement limits, and the possibility of residual refractive error.

This executive summary uses a structured review of peer-reviewed ophthalmology literature, clinical guidance, regulatory materials, health-system publications, and publicly documented technology and safety practices. Evidence was interpreted across procedure types, diagnostic workflows, patient-selection criteria, complications, and postoperative care. Regional, group, and country observations were synthesized from differences in healthcare infrastructure, regulation, specialist availability, financing, and access. Claims were limited to qualitative, verifiable themes; no market estimates, market shares, forecasts, or company-specific assessments were used.

Excimer-laser corneal refractive surgery is advancing through better diagnostics, individualized ablation planning, refined tracking, and stronger quality systems. The principal opportunity is not simply broader equipment deployment but safer integration of screening, treatment, follow-up, and patient-centered decision-making. Artificial intelligence may enhance this pathway when rigorously validated, transparently governed, and supervised by clinicians. Sustainable progress will depend on evidence-based protocols, trained teams, reliable infrastructure, equitable access, and continuous monitoring of real-world outcomes.